Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)May 31, 2025 | (Q2)Feb 28, 2025 | (Q1)Nov 30, 2024 | (FY)Aug 31, 2024 | (Q4)Aug 31, 2024 | (Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | (FY)Aug 31, 2023 | (Q4)Aug 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 534.42K | 0 | 0 | 448.01K | 448.01K | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --534.42K | --0 | --0 | --448.01K | --448.01K | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | 600.15K | 444.45K | 444.45K | 0 | 0 | |||||
| Gross profit | -65.73K | 3.56K | 3.56K | 0 | 0 | |||||
| Operating expense | -72.54%264.51K | 198.00%1.38M | 184.20%2.46M | 2,789.55%3.43M | 3,104.68%1.14M | 3,271.23%963.25K | 1,899.26%462.93K | 2,603.93%864.26K | -36.56%118.66K | 35.52K |
| Selling and administrative expenses | -87.31%85.14K | 288.57%1.11M | 153.95%2.06M | 8,677.96%2.57M | 4,406.15%800.6K | --670.78K | 4,152.25%286.05K | 16,526.55%810.21K | -56.14%29.25K | --17.77K |
| -Selling and marketing expense | -104.71%-1.97K | 2,062.90%110.83K | 12,297.70%902.06K | 2,573.06%218.42K | 107,469.51%164.27K | --41.75K | -23.83%5.12K | 430.32%7.28K | 441.13%8.17K | --152.7078 |
| -General and administrative expense | -86.15%87.11K | 256.20%1M | 43.91%1.16M | 11,044.34%2.35M | 3,512.63%636.34K | --629.03K | --280.93K | 22,834.48%802.94K | -67.66%21.08K | --17.61K |
| Research and development costs | --0 | --0 | ---- | --6.46K | --0 | --5.23K | --1.23K | ---- | --0 | --0 |
| Depreciation amortization depletion | 1.27%96.59K | 5.99%98.84K | 313.04%98.83K | 352.76%257.62K | 198.81%45.06K | 578.43%95.38K | 565.13%93.25K | 70.66%23.93K | 226.35%56.9K | --15.08K |
| -Depreciation and amortization | 1.27%96.59K | 5.99%98.84K | 313.04%98.83K | 352.76%257.62K | 198.81%45.06K | 578.43%95.38K | 565.13%93.25K | 70.66%23.93K | 226.35%56.9K | --15.08K |
| Other operating expenses | -56.85%82.78K | 105.32%169.19K | 895.73%299.88K | 1,736.43%597.02K | 10,843.60%292.64K | 1,221.91%191.86K | 3,321.97%82.4K | 130.44%30.12K | -68.41%32.51K | --2.67K |
| Operating profit | 65.72%-330.24K | -198.00%-1.38M | -184.20%-2.46M | -2,786.55%-3.43M | -3,094.67%-1.13M | -3,271.23%-963.25K | -1,899.26%-462.93K | -2,603.93%-864.26K | 36.56%-118.66K | -35.52K |
| Net non-operating interest income (expenses) | -5.84%-89.46K | 29.26%-54.63K | 30.15%-14.11K | -1,057.60%-229.62K | -981.74%-47.68K | -1,548.63%-84.52K | -1,411.71%-77.22K | -281.39%-20.21K | -191.11%-19.84K | -4.41K |
| Non-operating interest income | --1.5K | --1.18K | --11.86K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Non-operating interest expense | 7.61%90.95K | -27.73%55.81K | 28.54%25.97K | 1,057.60%229.62K | 981.74%47.68K | 1,548.63%84.52K | 1,411.71%77.22K | 281.39%20.21K | 191.11%19.84K | --4.41K |
| Other net income (expenses) | 102.06%92.18K | -19,853.62%-80.01K | -348.48%-4.56K | -295,415.38%-5.8M | -2,353,657.63%-1.32M | -4,758,505.18%-4.48M | -124.29%-401 | -661.88%-1.02K | 1.96K | 56.1082 |
| Gain on sale of security | 675.55%92.18K | -19,853.62%-80.01K | -348.48%-4.56K | ---3.28K | --14.16K | ---16.02K | ---401 | ---1.02K | ---- | ---- |
| Special income (charges) | --0 | ---- | ---- | ---5.82M | ---1.36M | ---4.46M | ---- | ---- | --0 | --0 |
| -Less:Restructuring and mergern&acquisition | --0 | ---- | ---- | --5.78M | --885.87K | --4.9M | ---- | ---- | --0 | --0 |
| -Less:Other special charges | ---- | ---- | ---- | ---2.59K | --430.89K | ---433.48K | ---- | ---- | ---- | ---- |
| -Less:Write off | ---- | ---- | ---- | --43.75K | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non-operating income (expenses) | ---- | ---- | ---- | 1,259.16%26.69K | 45,907.56%25.81K | 835.10%880 | ---- | ---- | --1.96K | --56.1082 |
| Income before tax | 94.07%-327.52K | -180.11%-1.51M | -179.50%-2.47M | -6,824.97%-9.45M | -6,177.59%-2.5M | -16,343.24%-5.53M | -1,931.22%-540.55K | -2,288.02%-885.48K | 29.57%-136.53K | -39.87K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 94.07%-327.52K | -180.11%-1.51M | -179.50%-2.47M | -6,824.97%-9.45M | -6,177.59%-2.5M | -16,343.24%-5.53M | -1,931.22%-540.55K | -2,288.02%-885.48K | 29.57%-136.53K | -39.87K |
| Net income continuous operations | 94.07%-327.52K | -180.11%-1.51M | -179.50%-2.47M | -6,824.97%-9.45M | -6,177.59%-2.5M | -16,343.24%-5.53M | -1,931.22%-540.55K | -2,288.02%-885.48K | 29.57%-136.53K | ---39.87K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 94.07%-327.52K | -180.11%-1.51M | -179.50%-2.47M | -6,824.97%-9.45M | -6,177.59%-2.5M | -16,343.24%-5.53M | -1,931.22%-540.55K | -2,288.02%-885.48K | 29.57%-136.53K | -39.87K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 94.07%-327.52K | -180.11%-1.51M | -179.50%-2.47M | -6,824.97%-9.45M | -6,177.59%-2.5M | -16,343.24%-5.53M | -1,931.22%-540.55K | -2,288.02%-885.48K | 29.57%-136.53K | -39.87K |
| Diluted earnings per share | 0 | -113.17%-0.02 | -160.28%-0.04 | -12,136.29%-0.29 | -5,620.66%-0.0396 | -16,350.26%-0.0959 | -1,930.74%-0.0094 | -2,286.34%-0.0154 | 29.55%-0.0024 | -0.0007 |
| Basic earnings per share | 0 | -113.17%-0.02 | -160.28%-0.04 | -12,136.29%-0.29 | -5,620.66%-0.0396 | -16,350.26%-0.0959 | -1,930.74%-0.0094 | -2,286.34%-0.0154 | 29.55%-0.0024 | -0.0007 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.